Skip to main content
. Author manuscript; available in PMC: 2011 Jan 24.
Published in final edited form as: Breast Cancer Res Treat. 2010 May 5;121(2):413–419. doi: 10.1007/s10549-010-0913-0

Table 2.

Changes in physiological outcomes over 3- and 6-month intervention

Variable C
n = 17
3M
n = 29
6M
n = 68
Pre Post Pre Post Pre Post
TM time (min ± SEM) 6.96 (0.5) 7.20 (0.6) 5.38 (0.5) 7.12 (0.5)*,# 5.22 (0.3) 6.85 (0.3)*,#
Pulmonary function
 FVC (%pred ± SEM) 103.4 (5.3) 98.5 (4.9) 108.5 (3.2) 109.6 (3.2) 88.6 (1.8) 92.8 (2.1)*,#,^
 FEV1 (%pred ± SEM) 92.2 (6.2) 92.8 (5.7) 100.9 (4.4) 104.2 (4.4) 83.6 (2.1) 89.2 (1.9)*
Muscular endurance
 Leg Pr (reps ± SEM) 20 (13) 32 (2.7)* 16 (1.3) 22 (3.2) 14 (1.0) 25 (1.6)*
 Bench Pr (reps ± SEM) 12 (9) 16 (1.9) 12 (0.9) 14 (1.1) 9 (0.6) 16 (0.8)*,^
 Lat PD (reps ± SEM) 16 (8) 23 (2.9)* 15 (1.7) 20 (2.2)* 13 (.8) 21 (1.7)*
 Sh Pr (reps ± SEM) 9 (5) 12 (1.5) 8 (0.7) 13 (2.0) 8 (0.5) 11 (0.4)
 Crunches (reps ± SEM) 29 (17) 25 (4.1) 17 (1.1) 26 (4.5)*,# 20 (1.2) 27 (1.9)*,#
*

P < 0.05 pre versus post

#

P < 0.05 versus control group

^

P < 0.05 versus 3-month group

HHS Vulnerability Disclosure